People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zogenix Inc | — | Pharmaceuticals | Series C | $131.2M | $526.4M | 2009 |
Cynthia Y. Robinson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cynthia Y. Robinson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam L. Garner | 1 | 11 |
| James C. Blair | 1 | 8 |
| Louis C. Bock | 1 | 7 |
| Kurt C. Wheeler | 1 | 3 |
| Erle T. Mast | 1 | 3 |
| Alex Zisson | 1 | 3 |
| Arda M. Minocherhomjee | 1 | 3 |
| Arda M. Minocherhomjee, Ph.D. | 1 | 2 |
| Ann D. Rhoads | 1 | 2 |
| Roger L. Hawley | 1 | 2 |
| Ken M. Haas | 1 | 2 |
| Ken T. Haas | 1 | 2 |
| Cam Garner | 1 | 2 |
| David W. Nassif | 1 | 2 |
| Stephen J. Farr | 1 | 1 |
| J.D. Haldeman | 1 | 1 |
| J.D. Y. Haldeman | 1 | 1 |
| Alex C. Zisson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.